Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hybrid vs High-dose Dual Therapy for H. pylori
NCT05152004Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Sep 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rabeprazole and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: The rates of H.pylori eradication. Started Sep 2018; status: completed.
02
Drugs
rabeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05152004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05152004.